Skip to content

Alpha Cognition Inc.

ACOG· Nasdaqxbrl foundCIK 1655923

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -1.95%
Market cap
$188.34M
22.04M shares
Filings
221
$7.78M
Q3 2026
—
-$7.62M
Q3 2026N/M FY25 yoy
-$6.43M
Q3 2026N/M FY25 yoy
-$23.79M
Q3 2026derivedN/M FY25 yoy
-$0.35
Q3 2026N/M FY25 yoy
$37.80M
Q3 2026+36.0% FY25 yoy
$188.34M
—
9.3×
3.8×
-16.37%
—

Twelve months to Sep 30, 2026 · derived

Price

$8.55+37.05%+$2.31past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$10.22MFY 2025
$10.22M0FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$10,220,275reported

Segments

Revenue by Geography, FY2025 to FY2025FY2025US · FY2025 · $6.79MCanada · FY2025 · $3.43M
LineFY2025ShareChange
US$6.79M66%—
Canada$3.43M34%—
Total$10.22M

From the 10-K filed Mar 31, 2026ACOG

Biological products, except diagnostic substances

Alpha Cognition Inc. is the 62nd largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Alpha Cognition Inc. · CIK 1655923 · Engraved from SEC EDGAR